Phase 2a Study of ASP5094 A Phase 2a, Randomized, Placebo-Controlled, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ASP5094 in Patients With Rheumatoid Arthritis on Methotrexate
Phase of Trial: Phase II
Latest Information Update: 13 Nov 2018
At a glance
- Drugs ASP 5094 (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Astellas Pharma
- 31 Oct 2018 Status changed from active, no longer recruiting to completed.
- 31 Aug 2018 Biomarkers information updated
- 11 Jul 2018 Status changed from recruiting to active, no longer recruiting.